Surveillance for familial melanoma: recommendations from a national centre of expertise
- PMID: 30742720
- DOI: 10.1111/bjd.17767
Surveillance for familial melanoma: recommendations from a national centre of expertise
References
-
- Read J, Wadt KAW, Hayward NK. Melanoma genetics. J Med Genet 2016; 53:1-14.
-
- Vasen H, Ibrahim I, Ponce CG et al. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers. J Clin Oncol 2016; 34:2010-19.
-
- van der Rhee JI, de Snoo FA, Vasen HFA et al. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. J Am Acad Dermatol 2011; 65:289-96.
-
- van der Rhee JI, Boonk SE, Putter H et al. Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation. Cancer Epidemiol Biomarkers Prev 2013; 22:1771-7.
-
- Plon SE, Eccles DM, Easton D et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008; 29:1282-91.